Updates and Events
Good News on Lupus Nephritis Discoveries from ACR Convergence 2020

November 19, 2020 The LRA is proud to share the extraordinary work presented at ACR Convergence 2020 by research members of the Accelerating Medicines Partnership Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) program (AMP RA/SLE).  AMP is a public-private partnership between the National Institutes of Health (NIH), eight biopharmaceutical companies, the LRA and several […] READ MORE

2021 Senate Budget Bill Includes Increases for Medical Research

November 11, 2020 The Lupus Research Alliance is pleased to share details of the 2021 spending package announced by the U.S. Senate last night with several potential “wins” for lupus research. While not 100% in line with our requests, funding for lupus research is substantial and due in large part to the hard work of […] READ MORE

Differences Found in Genes Among African and European Americans Point to Possible Lupus Drug Targets

November 10, 2020 Lupus affects individuals differently, from disease symptoms to responses to treatments.  Lupus patients of African ancestry often show significantly greater severity of lupus and respond to lupus drugs differently than lupus patients of European ancestry. In a collaboration among investigators at RILITE Foundation led by Dr. Peter Lipsky and Wake Forest School […] READ MORE

The LRA’s Forum for Discovery: Sharing the Latest News in Lupus Research

The Lupus Research Alliance (LRA) held our annual scientific conference, the Forum for Discovery, online in true 2020 fashion. More than 150 funded investigators, scientific advisors, and partners from the pharmaceutical and biotech industries logged on from their computers around the world to hear about new discoveries from LRA-funded researchers. LRA President Ken Farber emphasized […] READ MORE

Promising New Lupus Treatments Highlighted ACR Annual Meeting

Results of clinical trials testing potential lupus treatments were highlighted at the American College of Rheumatology’s annual meeting ACR Convergence 2020. These studies include phase I trials, which test for side effects and a safe dosage; larger phase II trials, which test for effectiveness and further gauge safety; and large phase III trials, which confirm […] READ MORE

LRA Highlights Full Continuum of Lupus Research at ACR Convergence 2020

30+ presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways Results from three clinical studies conducted in part by LRA-affiliate Lupus Therapeutics (LT) through its trials network 10 lupus presentations by the Accelerating Medicines Partnership Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) program (AMP RA/SLE) NEW YORK, NY, […] READ MORE

Less Risk and Greater Efficacy in Pediatric Lupus Nephritis Treatment

November 3, 2020 There is no doubt about it. The research into the mechanisms of pediatric lupus nephritis conducted by Elena Hsieh, MD, at the University of Colorado Anschutz Medical Campus, is driven by her genuine concern for the wellbeing of children—and a lifelong passion for science. With her new grant from the Lupus Research […] READ MORE

Vascular Injury and Dysfunction in Pediatric Lupus

November 3, 2020 While children with lupus can experience manifestations similar to adults with the disease, children present with more acute illness, more frequent flares, and increased risk of major organ involvement—including those of the heart. With her LRA grant, Joyce Chang, MD, MSCE from Children’s Hospital of Philadelphia, aims to understand why children with […] READ MORE

Lupus Advocate. Human Rights Defender. Teenager.

Aaliya Wears All These Hats … and More Lupus Advocate. Human Rights Defender. Teenager. Aaliya Wears All These Hats … and More It takes a brave, compassionate person to look beyond the personal pain of lupus and look for ways to create greater good. And it is even more remarkable when that person is a […] READ MORE

Join Lupus Research 2020 Virtual Fundraising Event

We can’t imagine November without all of you, so we reimagined our annual gala celebration—online. Using the very latest technology, the Lupus Research Alliance will host an unparalleled virtual event featuring inspirational speakers, star-studded performances, surprise celebrity guests, and recognition of the extraordinary contributions of Jenny and Spencer Zwick of Solamere Capital and the LRA […] READ MORE

Support the Combined Federal Campaign (CFC) For Lupus Treatments and a Cure

Fall, 2020 If you are employed by the Federal Government — a federal, postal, or military employee — you have a special chance to help transform the lives of people with lupus.  Last year, through the Combined Federal Campaign (CFC), thousands of federal employees pledged more than $86.4 million to worthy causes including the Lupus […] READ MORE

Lupus Research Alliance Announces Seven Recipients of the 2020 Lupus Innovation Award

NEW YORK, NY, November 9, 2020. The Lupus Research Alliance proudly announced today the 2020 Lupus Innovation Award recipients. These seven projects represent a wide breadth of scientific exploration in lupus, probing the development and progression of lupus while pointing to potential treatment approaches. The Lupus Innovation Award offers up to $150,000/year total costs for […] READ MORE

Together, ManyOne Can make a difference!
Stay informed about events, research developments, and ways you can help. Sign up for updates